New Diabetes Research Centre for the West

New Diabetes Research Centre for the West -image

Friday, 16 November 2012

9.6% of Irish Population with Diabetes Diabetes is now the commonest metabolic illness in the world and earlier this week marked World Diabetes Day (Wednesday, 14 November). An estimated 9.6% of the Irish population now have the disease. With a particularly high prevalence in the Western Region of the country, NUI Galway and Galway and Roscommon University Hospital Group have joined forces to create the Galway Diabetes Research Centre. The Galway Diabetes Research Centre (GDRC) will bring together an interdisciplinary research consortium of active researchers and clinicians. GDRC members comprise of individuals from across the diverse disciplines including psychology, engineering, economics, health promotion, nursing, midwifery, podiatry and information technology, all of whom have a track record in the field of diabetes. Based at NUI Galway, the GDRC will link researchers from these diverse disciplines to strengthen and develop close links with clinicians from Galway and Roscommon University Hospital Group and the hospitals linked to the NUI Galway regional Medical Academies.  Professor Fidelma Dunne,School of Medicine, Co-director of the GDRC explains: “This is an exciting opportunity for researchers and clinicians working in Diabetes at NUI Galway and Galway and Roscommon University Hospital Group. The centre will facilitate the development of each individual’s skills and provide the academic environment for collaboration. The collaboration between an academic institution and Health Care Delivery network will facilitate the efficient translation of research findings into clinical practice resulting in tangible benefits for patients with diabetes.” Bill Maher, CEO of the Galway and Roscommon University Hospital Group said: “This new research centre for Galway is another example of where the synergy of the Hospital and University can lead to tangible benefits for patients and improved outcomes. Diabetes is a growing health care problem which is putting additional strain on a public health service which will face funding difficulties for the foreseeable future; advances in research which lead to improved treatment and which enhance the skills of our clinicians will promote patient health and are to be welcomed.” Research clusters Through three main clusters: Aetiology and Prevention, Current and Future Clinical Management, and Population and Health Services Research, the GDRC will serve the needs of patients with diabetes mellitus and those at risk of developing diabetes mellitus by creating the treatments of the future through research, providing state of the art clinical care and developing the carers of the future through education.  The three main research clusters, capitalise on the already high volume of diabetes related work undertaken by the University and hospitals. 1. Aetiology and Prevention                                                                                     Aetiology and Prevention contributes to our understanding of how diabetes develops and what are the underlying mechanisms. Researchers in this cluster are active at every level of disease, from genes, through to glycoproteins and stem cells. 2. Current and Future Clinical management             Investigators in this strand are focused on the development of new therapies for diabetes mellitus. There is an active clinical trial programme through the HRB Clinical Research Facility, Galway, with the support of research nurses, quality assurance staff and biostatisticians. There is also a major focus on the development of biomaterials and stem cell based approaches to regenerative therapies through the Science Foundation Ireland funded research centres REMEDI and NFB. 3. Population and Health Services Research            This cluster will contribute to the evidence required to help address the many challenges of health care delivery in diabetes. These challenges include changing the way services are delivered, evaluating the health care needs of the diabetes population and measuring the relative effectiveness of interventions. The GDRC will be official launched on Friday, 16 November by Dr Jim Browne, President of NUI Galway, and Mr Bill Maher, CEO Galway and Roscommon University Hospital Group.  Speakers at the event will include: Professor Stephen O’Rahilly, University of Cambridge; Professor John Nolan, STENO Diabetes Centre Denmark; Professor James Shaw, Newcastle University; and Dr Peter Hammond, Harrogate District Hospital, UK. Sligo senior footballer, Mr Kenneth Sweeney also addressed the event who is 11 years living with type 1 Diabetes. Diabetes Statistics Diabetes is a chronic condition associated with significant morbidity and mortality. It is the commonest metabolic illness globally, according to the World Health Organisation, 346 million people worldwide have the condition. It is estimated that this figure will double by 2030.  About 90% of all diabetes is type 2. The prevalence of type 2 diabetes is increasing at an alarming rate in tandem with rising obesity rates. In Ireland the number of people with type 2 diabetes is growing as a result of an ageing population and rising obesity rates. The Diabetes Federation of Ireland estimated that 200,000 people had diabetes in Ireland in 2003 and a further 200,000 had the condition but were unaware of it. They also estimated that a further 250,000 had pre-diabetes and 50% would develop diabetes in the ensuing 5 years if lifestyle changes were not met. The Institute of Public Health (2005) concluded that 4.7% of the population (circa 150,000) of the Republic had established diabetes, with the highest prevalence in the Western Region (5.2%). The Institute of Public Health have revised their figures again (2012) and now conclude that 9.6% of the population have Diabetes. Ends

>> Read full story about New Diabetes Research Centre for the West

Report Points to Failure of State to Vindicate Rights of Children

Report Points to Failure of State to Vindicate Rights of Children-image

Friday, 16 November 2012

A report launched at NUI Galway today calls for the human rights of children of asylum seekers to be respected and criticises the current direct provision system. The situation facing hundreds of soon to be displaced asylum seekers, residents of Lisbrook House in Galway, also came in for sharp criticism. ‘Parenting in Direct Provision: Parent’s perspectives regarding stresses and supports’ was written by Helen Ogbu, a graduate of the MA in Family Support Studies in the UNESCO Child and Family Research Centre at NUI Galway. Parents interviewed in the report felt that their mental health problems and those of their childrenwere increased by prolonged stays in the centres, the strain of living in over-crowded rooms, poor diets, unavailability of recreational and study space, and the educational restriction for older children. She stated that: “Direct Provision is an unsuitable environment for children and families, that it is damaging to family life and that it is not in the best interests of the child.”Her report recommends that the policy of Direct Provision as it currently stands should be reviewed and that such communal accommodation should not be used for periods of longer than six months. The report was launched at an event hosted by NUI Galway and chaired by Professor Ray Murphy of the University’s Irish Centre for Human Rights. Opening the event Professor Murphy stated: “Of the 5,098 residents in Direct Provision, over one third are children. These children spend a significant proportion of their childhood in Direct Provision accommodation. This report indicates a failure of the state to vindicate rights set out in the UN Convention on the Rights of the Child and the family life rights set out in the European Convention on Human Rights in the case of children in the asylum system.” He added: “This is particularly shocking given the recent campaign on the amendment to the Constitution regarding children’s rights. In particular the situation for those children who have grown up and attend school in Galway, currently housed in Lisbrook House and who are to be scattered throughout the country give rise to concern on how this can be in the best interests of these children.” The audience of students, members of the public and asylum seekers also heard from Sade, an asylum seeker who has been living in the direct provision system for 5 years and 9 months and Samantha Arnold of the Irish Refugee Council. Samantha Arnold, Children’s and Young Persons’ Officer with the Irish Refugee Council Report has also recently published a report on the same topic entitled, ‘State sanctioned child poverty and exclusion:  the case of children in accommodation for asylum-seekers.’ She said “Both Fine Gael and Labour committed to reviewing the system of Direct Provision in July 2010. So far, those commitments haven’t been met. Under the Children First Guidelines, the conditions that children in Direct Provision live in amounts to child abuse or neglect. Despite not having chosen to live in Ireland or seek asylum here, the children living in and growing up in Direct Provision are subjected to enforced poverty, discrimination and social exclusion.” Samantha Arnold’s report makes a number of recommendations including ensuring that heating, hot water and cleanliness are guaranteed, children have access to private toilet facilities, children are not exposed to inappropriate behaviour, including that of a sexual or violent nature, and children are able to fully participate in the Irish education system. For further information and copies of this report visit http://www.irishrefugeecouncil.ie/children-and-young-people/children-in-direct-provision-accommodation/attachment/state-sanctioned-child-poverty-and-exclusion Ends

>> Read full story about Report Points to Failure of State to Vindicate Rights of Children

How Many Marine Organisms Are There?

How Many Marine Organisms Are There?-image

Friday, 16 November 2012

NUI Galway Marine Expert among International Researchers to Publish Findings In a landmark paper published in the prestigious international journal Current Biology 220 marine experts worldwide, including Professor Mike Guiry of NUI Galway’s Ryan Institute, have come together to estimate how many species there are in our oceans. The answer will come as something of a disappointment to those who claim more than a million marine species because the authors show that the true number is less than a quarter of that. About 225,000 species have been described to date, and the final tally is likely to be about 500,000. Previous estimates of a million marine species were based on unreliable figures passed from textbook to textbook and gaining credence when uttered by some famous individual at international conferences. Species are notoriously difficult to count. Unlike, say, books in a library, they are not discrete objects that can simply be catalogued and a final figure arrived at. The notion of a species is a human construct, essentially a philosophical notion, and the names we use for them, called binomials, are simply for us to communicate, and have no meaning without us. The numbers in this paper are the best that can be arrived at as, for once, they come from expert opinion, mainly from database curators and world experts in the various groups. One of these experts is Professor Mike Guiry of the Ryan Institute at NUI Galway. He is the founder of the database AlgaeBase (www.algaebase.org) funded in 2004-2009 by the Higher Education Authority under the Programme for Research in Third-Level Institutions, itself generously underwritten by Chuck Feeney, recently publically honoured by all the Irish universities, through Atlantic Philantrophies. Professor Guiry has to date catalogued 130,000 names of algae, including 34,000 species. Of these, about half are marine, and include some 9,500 seaweeds. This is the only global species database in Ireland. Speaking on the findings, Professor Guiry said: “We do not yet know how many species there are in the world, estimates vary from 5-50 million, but the most reliable recent estimates are that 1.9 million, with the insects accounting for more than 1 million.” Professor Guiry added: “The marine environment is relatively species-poor, despite claims to the contrary, with less than 12% of all currently described species occurring in the sea. But what the sea lacks in species numbers it makes up spectacularly in diversity and beauty, and in the active part these organisms play in keeping our planet healthy. More than 75% of all photosynthetic oxygen is produced by marine algae.” The marine Professor’s forthcoming book, A Catalogue of Irish Seaweeds, will show that 7.5% of all seaweeds occurs in Ireland, which is extraordinary for the size and geographical spread of the island, and contrasts strongly with our native flowering-plants, which amount to no more than 0.25% of the world’s 350,000-400,000 species. The marine experts predict that all marine species will have been described by the end of this century, so that the task will have taken the human race 350 years. ENDS

>> Read full story about How Many Marine Organisms Are There?

Bardic Voices, Horns and Medieval Harps Focus of NUI Galway Concert

Bardic Voices, Horns and Medieval Harps Focus of NUI Galway Concert-image

Monday, 19 November 2012

On Friday, 30 November, NUI Galway's Aula Maxima will resound with the ancient sounds of early Irish harp, voice and horn.  Gold-strung cláirseachs (harps), played by Ann Heymann, will accompany 7th-18th century Gaelic poems, including genres of laoi, rosc and amhrán, sung by Charlie Heymann and NUI Galway’s Lillis Ó Laoire.  Ann Heymann is a Visiting Fellow with the Moore Institute for Research in the Humanities and Social Studies, NUI Galway where she is studying the use of the harp in the performance of early Irish poetry.  Early Welsh poetry by the famous poets Aneirin and Taliesin, accompanied by horsehair harp, crwth and various lyres will also featured.  Adding to the musical soundscape will be Simon O'Dwyer's pre-historic and medieval horns, bells and pipes. Dr Lillis Ó Laoire, Lecturer in Irish and Head of NUI Galway’s School of Languages, Literatures and Cultures, is an award winning sean-nós singer, scholar, and writer from the Gaelic speaking region of Donegal. Dr O’Laoire teaches courses in Gaelic language, culture and folklore at NUI Galway, and his publications include On a Rock in the Middle of the Ocean: Songs and Singers in Tory Island, Ireland. Ann Heymann is renowned for having recreated specialised techniques that articulate the voice of the cláirseach. Her use of gold wire, which is based both on evidence in the literature and in the physical construction of the cláirseach, has restored a brilliant rich voice to the instrument. Her husband Charlie is both a vocalist and instrumentalist, and for over 35 years the couple have performed and taught across four continents.   Simon O'Dwyer has brought the sound of ancient Irish horns, bells and pipes to audiences around the globe.  Author of Prehistoric Music of Ireland, O'Dwyer documents both his research and his making of these reproduction instruments. This event is free and open to the public and takes place at 7pm in the Aula Maxima, NUI Galway. -ENDS-

>> Read full story about Bardic Voices, Horns and Medieval Harps Focus of NUI Galway Concert

Stem Cell Clinical Trials to Tackle Diabetes

Stem Cell Clinical Trials to Tackle Diabetes-image

Monday, 19 November 2012

NUI Galway’s REMEDI and Orbsen Therapeutics win €6 million European funding NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications. Professor Timothy O’Brien, Director of the Regenerative Medicine Institute (REMEDI) at NUI Galway, who is also a Consultant in Endocrinology at Galway University Hospitals, will co-ordinate the project. Orbsen Therapeutics Limited, an NUI Galway spin-out company, is the lead SME on the project. Clinical trials will take place in Ireland and Denmark using stem cells discovered by Orbsen. In total, nine new research jobs are to be created in Ireland by the project. An estimated 60 million patients with diabetes mellitus in the EU are using prescription drugs to control blood glucose levels. Poor control of blood glucose levels may lead to a number of diabetic complications, including: nephropathy, retinopathy, cardiomyopathy, neuropathy, impaired bone repair and wound ulceration. “At the moment, there are very few treatment options available to control the initiation and progression of these complications”, explains Professor O’Brien. “In addition, there are no treatments which will improve glucose levels and simultaneously treat the diabetic complication. These complications therefore continue to be a major challenge for clinicians and patients alike.” The REDDSTAR project, originally conceived by Dr Steve Elliman, Head of Research & Development at Orbsen Therapeutics, will take place over two phases. The first will examine which diabetic complication responds best to stem cell treatment in various models of diabetes. The second phase will involve a clinical trial at the Steno Diabetes Centre in Denmark, in collaboration with clinicians at the Diabetes Centre in Galway University Hospitals, specifically in the complication which showed the most promising results in the first phase. Orbsen Therapeutics Limited was formed as a spin out company to advance and commercialise new intellectual property developed by researchers at the SFI-funded REMEDI at NUI Galway. The University has become a leading centre of translational research in adult stem cells involving its National Centre for Biomedical Engineering Science (NCBES) and REMEDI. Co-ordinated by NUI Galway, the REDDSTAR (Repair of Diabetic Damage by Stromal Cell Administration) project brings together ten expert teams from Ireland, Northern Ireland, Germany, the Netherlands, Denmark, Portugal and the US will comprehensively examine if stem cellscan safely address this challenge. Converting research funding into job creation The REDDSTAR EU FP7 funding will be used to create three new positions within REMEDI and a further five new positions at Orbsen. Administration of the REDDSTAR project will be supported by a third SME, Dublin-based EU specialists Pintail Ltd, bringing the total number of new Irish jobs created by this project to nine. Professor O’Brien states: “The creation of new jobs is a very important impact of government-funded research through Science Foundation Ireland (SFI). The funding of REMEDI by SFI has allowed this EU support to be leveraged resulting in job creation in Ireland.”  Orbsen CEO Brian Molloy adds: “Our participation in REDDSTAR assists us in the development of our core stem cell technology and will make a substantial contribution to our R&D programme. Our mission is to become Europe’s leading Stem Cell Therapy company. Collaborations such as this with REMEDI and NUI Galway help to position Ireland as a European hub for cell therapy development.” Orbsen recently developed and is patenting a unique method of isolating therapeutic stem cells from human tissue at class-leading levels of purity. The Orbsen cell therapy product is unique in that it has been designed to meet future EU regulations regarding cell-based medicines. The Orbsen therapy will be independently assessed by the REDDSTAR experts in each diabetic complication.   Dr Steve Elliman, states: “This project design has a number of advantages over similar approaches being taken by other researchers. Primarily, this is the first FP7 project to unite EU experts on all six diabetic complications to work together and assess how a therapy might impact all six tissues at the same time. It is expected that this REDDSTAR ‘network’ of researchers will live beyond this project and be used by other drug developers.” In addition, REDDSTAR has permitted a unique collaboration between Orbsen and the US-based SME, Owl Biomedical Inc. Owl Biomedical is developing the unique “Nanosorter”, a bench-top device that will permit isolation of the Orbsen cell therapy for clinical use in line with forthcoming EU regulations. -ends-

>> Read full story about Stem Cell Clinical Trials to Tackle Diabetes

NUI Galway to Hold Information Evening in Clonmel

NUI Galway to Hold Information Evening in Clonmel-image

Monday, 19 November 2012

Secondary school students interested in NUI Galway are invited to an information evening in Clonmel on Wednesday, 28 November. Parents and guardians are also particularly welcome to the event which runs from 7-9pm in the Clonmel Park Hotel, Clonmel, Co. Tipperary. The evening will begin with short talks about NUI Galway and some of the 60 courses it offers. Afterwards, current students and NUI Galway staff will be on hand to answer any questions in relation to courses and practical issues like accommodation, fees and scholarships, and the wide range of support services available to students. The ever-increasing popularity of NUI Galway is in-part due to a whole suite of innovative new programmes, developed in response to the changing needs of the employment market. Unique programmes include a Bachelor of Arts with Human Rights, an Energy Engineering degree which is taught in the University’s new Engineering Building, Ireland’s largest School of Engineering, and a Maths and Education degree aimed at training maths teachers. Visitors to the information evening will also get information on NUI Galway’s newest degree programmes, a BA in Drama, Theatre and Performance Studies and a Bachelor of Arts with Journalism which are brand new for 2013. “NUI Galway has a great deal to offer. Our own students tell us our lecturers are inspirational and challenge them to achieve their full potential. The student experience in Galway is second to none, and we want to bring a taste of that to Tipperary, while also providing all the practical information on accommodation, CAO points, fees, scholarships and courses. With so many courses on offer, this event in Clonmel is a perfect opportunity to meet current students and our lecturers to see what degree might be the right fit”, says Caroline Loughnane, Director of Marketing and Communications at NUI Galway. To find out more about the information evening in Clonmel, contact NUI Galway’s Schools Liaison Officer, Celine O’Donovan on 087 239 1219 or celine.odonovan@nuigalway.ie. ENDS

>> Read full story about NUI Galway to Hold Information Evening in Clonmel

Mary Robinson Visits NUI Galway to Mark the Beginning of New Ballina Visitor Centre

Mary Robinson Visits NUI Galway to Mark the Beginning of New Ballina Visitor Centre-image

Monday, 19 November 2012

Former President of Ireland, Mary Robinson, visited NUI Galway this weekend to mark the beginning of a new partnership with the University. Recent plans have been unveiled to establish a Mary Robinson Centre in the former President’s home town of Ballina, Co. Mayo. The Centre, supported by Mayo County Council and Ballina Town Council will be established at Mary Robinson’s birthplace and will include both a Visitor Centre and an academic research centre, supported by NUI Galway and focused on scholarly research and education in the fields of Human Rights and Women’s Leadership. Speaking at NUI Galway, Mary Robinson also announced details of a public interview on her life and work, with Fintan O’Toole, to take place at NUI Galway on January 14, 2013. Mary Robinson’s archive will be the centrepiece of the educational facility, and as academic partner to the project, NUI Galway will bring researchers and students from all over the world to Ballina to engage with the archive. NUI Galway is internationally recognised as a leader in the field of Human Rights and Gender research, and offers undergraduate degrees and Masters programmes in the area. The University will also advise on the cataloguing and making available of the extensive archive which is valued at over €2.5 million. President Jim Browne of NUI Galway commented: “We at NUI Galway are delighted to have been invited to become involved in this project.  We believe that the Mary Robinson Archive is very important  for scholarship globally; for our region – it adds a truly unique piece of infrastructure to the knowledge capital of the West of Ireland; and for Ireland as a nation  preserving the narrative of the life and work of probably the most significant figure to emerge from our country – a transformative figure of modern Ireland – Mary Robinson.” The proposed Visitor Centre, which is set to open to the public by the end of 2014, will provide a unique cultural tourism resource for Mayo as visitors will have the opportunity to learn more about Mary Robinson’s life and work, including her early roots in Ballina. The project will involve the refurbishment of Victoria House, a protected 19th century Georgian house, together with the construction of an Annex to the house. Parts of the house will be recreated to its original condition at the time of Mary Robinson’s birth in 1944. The property at Victoria House, which has been in the Bourke Family for generations, is being made available to the Centre by the owner, Mary’s brother Adrian Bourke, and will be leased in perpetuity. Mary Robinson’s archive is a vast collection illuminating the life and career of one of Ireland’s most distinguished public figures. The archive includes a library of books, and periodicals, Mary Robinson’s personal diaries, working files and detailed records of her career as a champion of human rights and women’s equality. Also included are numerous recordings and manuscripts from her time as President of Ireland. ENDS

>> Read full story about Mary Robinson Visits NUI Galway to Mark the Beginning of New Ballina Visitor Centre

Accessing a Wealth of Medical Information

Accessing a Wealth of Medical Information-image

Tuesday, 20 November 2012

A new €4.4 million EU project A new €4.4 million EU project is using the latest web technologies to make the most of the wealth of medical information contained in electronic medical records. The project aims to aid decision-making for medical practitioners and improve safety in clinical research. The Linked2Safety project will build a medical and clinical data management infrastructure, using privacy-aware, semantic technology. At the forefront of technologies being deployed by the project, are researchers from the Digital Enterprise Research Institute (DERI) at the National University of Ireland Galway. Their task is to imbue meaning into the data contained within the European healthcare information space, which is fragmented and disparate, and connect that data. To do so, the project will use ‘linked-data’ and other sematic technologies developed by DERI. “So much valuable information sits in seclusion in medical records in hospitals across Europe. They have the potential to significantly help and advance medical research, as well as improve health policies,” explains Ronan Fox, Health Care and Life Sciences Leader at DERI. “What we need to do is put in place a framework so that the information can be interconnected, this could lead to all kinds of possibilities. For example, within the context of the data governance, and legal and ethical framework created in Linked2Safety, individuals could be identified to join a clinical trial for a rare disease, whether they are in Ireland or Cyprus.” In addition, using ‘linked data’, information contained in the records will be leveraged in clinical research for the early detection of potential patient safety issues. Such issues might be based on genetic data analysis and the extraction of the bio-markers associated with an identified type of an adverse event. The Linked2Safety project will also support the effective organization and execution of clinical trials by allowing health carers and medical scientists to easily submit their own query and get homogenized access to high-quality medical data. Linked2Safety is an FP7 project funded by the European Commission under the area of ICT for health. With over 140 researchers, DERI is the largest web science institute of its kind in the world, set up in 2003 with funding from Science Foundation Ireland and the National University of Ireland Galway. -ends-

>> Read full story about Accessing a Wealth of Medical Information

REMEDI Strengthen Chinese Research Links

REMEDI Strengthen Chinese Research Links-image

Tuesday, 20 November 2012

Officials from the Chinese Government Ministry of Science and Technology (MOST) visited the Regenerative Medicine Institute (REMEDI) at NUI Galway last week.  Organised by the Embassy of the People’s Republic of China in Ireland, the visit was a follow-up to the signing of collaborative research agreements between REMEDI and two Chinese research institutes based in Shanghai and Xi’an earlier this year. The collaboration will see the partners work together in the areas of regenerative medicine clinical trials, particularly in the areas of diabetes and orthopaedics.  As part of their visit the officials from MOST had the opportunity to see the Centre for Cell Manufacturing Ireland (CCMI) at NUI Galway, which is a specially designed facility for manufacturing GMP-grade stem cells for use in human clinical trials. At present there is no similar facility in China. REMEDI hopes to work with its collaborators and the Chinese Government to help set up similar resources in China, ultimately opening up new opportunities for partnership in the area of clinical trials using stem cells. Professor Timothy O’Brien, Director of REMEDI states, “We look forward to undertaking collaborative clinical trials using stem cells in Ireland and China. This will allow efficacy to be assessed in different ethnic populations and will also serve to harmonize transnational conduct of such trials.” “We highly appreciate that NUI Galway has been actively developing close scientific collaborations with Chinese institutions in recent years”, added Liya Dong, Deputy Director General, Department of Science & Technology Development, MOST, “and we strongly support Ireland-China bi-lateral collaborations in life science and other areas, and will do our best to provide assistance for promoting the collaborations between NUI Galway and the Chinese Institutions in Shanghai and Xi’an.” The Regenerative Medicine Institute (REMEDI) is a Science Foundation Ireland-funded Strategic Research Cluster, led by NUI Galway and with partners in University College Cork and NUI Maynooth. REMEDI is a partnership between scientists, clinicians and industry and it is the leading centre in the area of stem cell and regenerative medicine in Ireland. -ends-

>> Read full story about REMEDI Strengthen Chinese Research Links

Winter Conferrings at NUI Galway

Winter Conferrings at NUI Galway -image

Wednesday, 21 November 2012

First Podiatry Students in Ireland to Graduate Over 1400 students, including the first Podiatry students in the country, will graduate from across the five colleges at NUI Galway at the University's winter conferring ceremonies, which take place from today, Wednesday 21 to Friday, 23 November. George Cunningham will also be conferred with an honorary Master of Arts degree. From Roscrea, Co. Tipperary, George Cunningham is a former Principal of Coolderry Central School, Birr, Co. Offaly. He was prominently associated with the successful campaign to save and subsequently restore Damer House in his native Tipperary town of Roscrea. He founded there, in 1980, Ireland’s first heritage centre together with the Roscrea Heritage Society, of which he is still President and honorary Life Member.  He has been deeply involved with every aspect of Irish heritage tourism during the past thirty years. He receives this honorary degree in recognition of his enormous contribution to heritage, conservation and education. The winter conferring will see the first cohort of graduates from the discipline of Podiatry in the School of Health Sciences at the University, which is the only undergraduate programme available in the Republic of Ireland leading to a BSc (Hons) in Podiatry. 13 students will graduate, qualifying after four years of study as healthcare professionals specialising in the management of disease and disorders of the lower limb and foot. Speaking in advance of the ceremonies, President of NUI Galway, Dr Jim Browne, said: “The graduation of the first cohort of podiatry graduates in Ireland is a historic milestone.  We are delighted to have worked closely with colleagues in the HSE and with international experts to develop this new programme. I am also pleased that this week we will honour the achievements of George Cunningham, an enlightened educationalist and custodian of Irish heritage, by conferring him with an honorary degree.  In addition, degrees, higher diplomas, Masters and PhDs will be awarded to students graduating over the three days from the College of Medicine, Nursing and Health Sciences; College of Engineering and Informatics; College of Business, Public Policy and Law; College of Science; and the College of Arts, Social Sciences and Celtic Studies. -Ends-

>> Read full story about Winter Conferrings at NUI Galway

<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 > >>

Press office

E info@nuigalway.ie
T +353 (0)91 493361

Press member?

Visit our press centre

Connect & share